Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
60 hedge funds and large institutions have $28.8M invested in Avid Bioservices, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 12 closing their positions.
214% more call options, than puts
Call options by funds: $22K | Put options by funds: $7K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
11% more capital invested
Capital invested by funds: $26M → $28.8M (+$2.83M)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
2% less funds holding
Funds holding: 61 → 60 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSP
Tappan Street Partners
Chicago,
Illinois
|
+$3.04M |
| 2 |
BP
Bandera Partners
New York
|
+$831K |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$601K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$601K |
| 5 |
Renaissance Technologies
New York
|
+$170K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$473K |
| 2 |
Morgan Stanley
New York
|
-$212K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$210K |
| 4 |
BlackRock
New York
|
-$202K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$128K |
CDMO Hedge Fund Activity: Q2 2017 in Review
60 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2017, worth a combined $28.8M — up 11% from $26M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CDMO and 11 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 17 added.
The largest buyer was Tappan Street Partners, adding an estimated $3.04M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $473K sold.
- 60 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2017, down from 61 in Q1 2017.
- Funds reported $28.8M of Avid Bioservices, Inc. Common Stock stock for Q2 2017, up 11% quarter-over-quarter.
- 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2017 and 12 closed out, a net change of -1 holder.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2017 was Tappan Street Partners, an estimated $3.04M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2017 was Acadian Asset Management, an estimated $473K sold.
Based on aggregated 13F filings for Q2 2017.